COGENDX

Medical testing services for diagnostic or treatment purposes marketed and sold to healthcare providers and insurers, namely, third-party testing of patient oral fluids, skin specimens, or wound specimens; medical services, namely, DNA testing services to evaluate patient treatment plans and improve clinical outcomes and patient safety; pharmacogenetic testing services for detection or treatment purposes to predict a how a patient's genetic makeup may impact the patient's response to specific medications; medical testing service for detection of infectious agents and identification of appropriate antimicrobial therapy to improve clinical outcomes; medical testing services permitting clinicians to tailor surgical and anesthesia plans to each patient to optimize surgery outcomes; medical testing services for wound care